Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03377036 | Breast Cancer Screening: Digital Breast Tomosynthesis Versus Digital 2D Mammography(TOSYMA) | active not recruiting | N/A | 99,689 | University Hospital MuensterOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT03878342 | Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast(ROMANCE) | active not recruiting | N/A | 295 | UNICANCEROTHER | 1 | Jan 23, 2026 |
| NCT05731791 | Trial to Compare MRI-guided Precision Prone Irradiation (PPI) Versus CT-guided Breast Irradiation(PPI) | active not recruiting | N/A | 17 | Weill Medical College of Cornell UniversityOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT04871516 | Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer | active not recruiting | N/A | 103 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT05529862 | Trans-RosaLEE Study: a Biomarker-directed, Translational Study(TransRosaLEE) | active not recruiting | N/A | 115 | Institut Paoli-CalmettesOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT06519370 | FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer | active not recruiting | Phase 3 | 350 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 22, 2026 | clinicaltrials |
| NCT03879577 | Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer | active not recruiting | Phase 2 | 53 | University of ChicagoOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT03891953 | Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. | active not recruiting | Phase 1 | 98 | Novartis PharmaceuticalsINDUSTRY | 6 | Jan 21, 2026 | clinicaltrials |
| NCT04509648 | Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer(ARROW) | active not recruiting | N/A | 197 | Ruijin HospitalOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05327452 | Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study | active not recruiting | N/A | 135 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05301114 | Social Risk Factors and Discrimination in Cancer Survivorship | active not recruiting | N/A | 1,116 | Medstar Health Research InstituteOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT05169567 | Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer(postMONARCH) | active not recruiting | Phase 3 | 368 | Eli Lilly and CompanyINDUSTRY | 17 | Jan 16, 2026 | clinicaltrials |
| NCT04448886 | Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC | active not recruiting | Phase 2 | 110 | Ana C Garrido-Castro, MDOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT06833723 | Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes | active not recruiting | — | 1,000 | Hangzhou Institute of Medicine (HIM), Chinese Academy of SciencesOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT04320979 | Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients | active not recruiting | Phase 3 | 2,400 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jan 13, 2026 | clinicaltrials |
| NCT05826964 | Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer | active not recruiting | Phase 2 | 24 | University of MiamiOTHER | 1 | Jan 13, 2026 | clinicaltrials |
| NCT02284919 | [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer(ISO-1Primary) | active not recruiting | Phase 1 | 30 | University of PennsylvaniaOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT04630080 | Alopecia Prevention Scalp Cooling in Chinese Breast Cancer Patients | active not recruiting | N/A | 25 | Chinese University of Hong KongOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT00579163 | Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers | active not recruiting | — | 992 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT00588029 | Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer | active not recruiting | — | 7,000 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT04290793 | Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer | active not recruiting | Phase 2 / Phase 3 | 113 | Hebei Medical University Fourth HospitalOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT04872985 | Pyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast Cancer | active not recruiting | Phase 2 | 140 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT05544929 | A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers | active not recruiting | Phase 1 | 126 | Novartis PharmaceuticalsINDUSTRY | 12 | Jan 6, 2026 | clinicaltrials |
| NCT01196936 | Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors(LDTam) | active not recruiting | Phase 2 | 84 | University of Alabama at BirminghamOTHER | 2 | Jan 5, 2026 | clinicaltrials |
| NCT03344965 | Olaparib In Metastatic Breast Cancer | active not recruiting | Phase 2 | 114 | Beth Israel Deaconess Medical CenterOTHER | 1 | Jan 5, 2026 | clinicaltrials |
| NCT05023967 | Metformin and Nightly Fasting in Women With Early Breast Cancer | active not recruiting | Phase 2 | 120 | M.D. Anderson Cancer CenterOTHER | 2 | Jan 5, 2026 | clinicaltrials |
| NCT06418126 | Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer(TNBC-RT2023) | active not recruiting | N/A | 15 | Centre Paul StraussOTHER | 1 | Jan 5, 2026 | clinicaltrials |
| NCT07316439 | Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer | active not recruiting | — | 197 | Fudan UniversityOTHER | 1 | Jan 5, 2026 | clinicaltrials |
| NCT07317765 | Research on New Methods and New Models of Rehabilitation Intervention for Cancer Patients Based on Exercise and Psychological Intervention | active not recruiting | N/A | 200 | Beijing HuiLongGuan HospitalOTHER | 1 | Jan 5, 2026 | clinicaltrials |
| NCT03090165 | Ribociclib and Bicalutamide in AR+ TNBC | active not recruiting | Phase 1 / Phase 2 | 37 | Kari WisinskiOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT03393845 | Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients | active not recruiting | Phase 2 | 47 | Nancy Chan, MDOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT04762979 | Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer | active not recruiting | Phase 2 | 44 | Marina N SharifiOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT04141449 | A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation(Potlako+) | active not recruiting | Phase 2 | 874 | Brigham and Women's HospitalOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT02051218 | Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks | active not recruiting | Phase 3 | 1,380 | Swiss Cancer InstituteOTHER | 3 | Dec 30, 2025 | clinicaltrials |
| NCT02276885 | Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial | active not recruiting | N/A | 284 | NYU Langone HealthOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07311278 | Identification of Sentinel Lymph Nodes Using Indocyanine Green in Breast Cancer Patients(INFLUENCE II) | active not recruiting | N/A | 493 | St. Antonius HospitalOTHER | 2 | Dec 30, 2025 | clinicaltrials |
| NCT04989179 | Incidence and Factors Affecting the Development and Outcome of Post Mastectomy Pain Syndrome(PMPS) | active not recruiting | — | 220 | Singapore General HospitalOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT05278741 | Functional Evaluation After Breast Reconstruction With a Minimally Invasive Latissimus Dorsi Flap Following Radical Surgery for Breast Cancer.(BREAST) | active not recruiting | N/A | 32 | Centre Georges Francois LeclercOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT03892655 | Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer(LB1802) | active not recruiting | — | 170 | Libbs Farmacêutica LTDAINDUSTRY | 1 | Dec 24, 2025 | clinicaltrials |
| NCT05305365 | Study Assessing QBS72S For Treating Brain Metastases | active not recruiting | Phase 2 | 21 | Stanford UniversityOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT03285412 | CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer(LEADER) | active not recruiting | Phase 2 | 120 | Massachusetts General HospitalOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT03997123 | Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC(CAPItello-290) | active not recruiting | Phase 3 | 923 | AstraZenecaINDUSTRY | 30 | Dec 22, 2025 | clinicaltrials |
| NCT04537312 | Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM) | active not recruiting | N/A | 4 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT01081288 | Extending the National Health Service (NHS) Breast Screening Age Range(AgeX) | active not recruiting | N/A | 4,000,000 | University of OxfordOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT02050750 | TAILORx Tissue Bank | active not recruiting | — | 600 | Cancer Trials IrelandNETWORK | 1 | Dec 19, 2025 | clinicaltrials |
| NCT02352883 | MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ | active not recruiting | N/A | 368 | ECOG-ACRIN Cancer Research GroupNETWORK | 1 | Dec 19, 2025 | clinicaltrials |
| NCT03818087 | Elevate! : An Elderly Breast Cancer Cohort Study | active not recruiting | — | 253 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT04603820 | Registry Study of Pregnancy and Breast Cancer(EMBARCAM) | active not recruiting | — | 866 | Spanish Breast Cancer Research GroupOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT07293052 | Comparison of Outcome Between Grisotti Flap Versus Reverse Mirror Grisotti Flap for Central Quadrant Breast Tumors(GRISOTTI FLAP) | active not recruiting | N/A | 106 | Mayo Hospital LahoreOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT04532177 | Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery(SBRT BREAST) | active not recruiting | N/A | 15 | Stony Brook UniversityOTHER | 1 | Dec 17, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Jan 23, 2026source: clinicaltrials